Anti-platelet Therapy in the Primary Prevention of CardiovascuLar DisEase in Patients with Chronic Obstructive Pulmonary Disease

• Status: Closed
• Sponsor: The Newcastle upon Tyne Hospitals NHS Foundation Trust
• Funder: Astra Zeneca
• Therapeutic area: Cardiovascular
• Type of study: CTIMP

Aim: To investigate if treatment with antiplatelet therapy (APT) will produce a response in platelet function measured using the Multiplate test in patients with chronic obstructive pulmonary disease (COPD).

Primary Outcome:

Inhibition of ASPI and ADP-induced platelet aggregation at 6-month

• Population: Adult
• Design: RCT
• Setting: Secondary Care
• Planned Sample Size: 120